Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis

NCT02141672 is registered in ClinicalTrials.gov with Aurinia Pharmaceuticals Inc. as lead sponsor.

NCT NCT02141672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02141672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
Lead sponsor
Aurinia Pharmaceuticals Inc.
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2014
Completion date
January 31, 2017
Enrollment
265 (actual)
Sites
86

Conditions

As the registry lists them; a condition with its own page is linked.

lupus nephritis